Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now
Close

Array BioPharma Inc (ARRY_old)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Array BioPharma's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Array BioPharma historical data, for real-time data please try another search
47.850 0.000    0.00%
04/02 - Real-time Cboe. Currency in USD ( Disclaimer )
Type:  Equity
Market:  United States
  • Volume: 0
  • Bid/Ask: 0.000 / 0.000
  • Day's Range: 47.840 - 47.980
Array BioPharma 47.850 0.000 0.00%

NASDAQ:ARRY_old Financials

 
A brief overview of the NASDAQ:ARRY_old financials. This summary provides an overview of the most significant critical numbers from each of its financial reports, including the income statement, balance sheet, and cash flow statement. Additionally, it features several financial ratios that provide insight into the company's financial health. Users can select to view data from four periods of either annual or quarterly information, allowing them to track financial performance of Array BioPharma over time.

For the six months ended 30 June 2020, Array Technologies Inc revenues increased from $225.4M to $552.6M. Net income totaled $76.1M vs. loss of $5.2M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Net Income reflects Interest expense decrease of 19% to $7.6M (expense), Depreciation and amortization - Balancin decrease of less than 1% to $12.6M (expense).

AnnualQuarterly  
InvestingPro Advanced Financial Summary
TTM = Trailing Twelve Months
MRQ = Most Recent Quarter

ARRY_old Income Statement

Gross margin TTM -
Operating margin TTM -
Net Profit margin TTM -
Return on Investment TTM -
 Total Revenue  Net Income
Period Ending: Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018
Total Revenue 64.68 82.55 56.91 35.44
Gross Profit 63.63 81.76 56.72 19.25
Operating Income -37.45 -10.83 -23.73 -46.95
Net Income -37.49 -11.36 -24.81 -52.45

ARRY_old Balance Sheet

Quick Ratio MRQ -
Current Ratio MRQ -
LT Debt to Equity MRQ -
Total Debt to Equity MRQ -
 Total Assets  Total Liabilities
Period Ending: Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018
Total Assets 567 548.96 484.22 460.36
Total Liabilities 265.38 263.61 265.15 240.62
Total Equity 301.62 285.35 219.07 219.74

ARRY_old Cash Flow Statement

Cash Flow/Share TTM -
Revenue/Share TTM -
Operating Cash Flow  -100.89%
 Cash  Net Change in Cash
Period Ending: Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018
Period Length: 9 Months 6 Months 3 Months 12 Months
Cash From Operating Activities -87.43 -43.44 -34.8 -119.78
Cash From Investing Activities -84.59 -32.95 13.74 -191.04
Cash From Financing Activities 153.9 108.73 36.82 299.63
Net Change in Cash -18.11 32.35 15.76 -11.19
* In Millions of USD (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

ARRY_old Comments

Write your thoughts about Array BioPharma Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Jeff Bailey
JeffB Jun 17, 2019 9:37AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Selling to close ARRY Jan17 2020 $25 C @ $21.90.
Mark Stone
Mark Stone Jun 17, 2019 8:51AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Spent to much time watching, not enough buying
Jeff Bailey
JeffB Jun 06, 2019 5:42PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
ARRY $27.78 -0.07% ... Printed a doji on 6/5/19. might be time to take a rest and consolidate.
Jeff Bailey
JeffB May 21, 2019 1:29PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
ARRY $25.40 +21%
WTI Trader
WTI Trader May 21, 2019 1:29PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
good for you!
Abhishek M R
Abhishek M R Jul 24, 2013 1:15PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
ARRY Is a Buy @ 6.18 - 6 for target 7.10 - 7.40 , stops below 5.8 #stocks #mkt #trade
Jeff Bailey
JeffB Jul 24, 2013 1:15PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Nice!  $20.73 today and new 52-weeker!
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email